Tirzepatide was developed by Eli Lilly as a dual-agonist drug that acts on both GLP-1 and GIP receptors
The study found that people with diabetes who were prescribed semaglutide, most commonly known under the brand names Wegovy and Ozempic, were more than four times more likely to be diagnosed with an eye condition known as non-arteritic anterior ischemic optic neuropathy (naion)
Her discovery opened up whole new therapeutic approach to hyperglycemia, ultimately paving the way for development of Ozempic, Wegovy, and Victozablockbuster drugs now used by millions to manage diabetes and lose weight
Mater 32 (10), 1905823
Saxenda (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI 27) who also have weight-related medical problems or obesity (BMI 30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off
For this reason, the subcutaneous route remains the only clinically validated method of administration